-
The University of Manchester is seeking a talented bioinformatician to lead the analysis of Whole Genome Sequencing data from oesophageal cancer patients undergoing care in hospitals in Nairobi
-
, University of Manchester Employment type: Fixed Term Division/Team: Division of Psychology and Mental Health Hours Per Week: 1 FTE Closing date: 17/04/2024 Contract Duration: 45 Months School/Directorate
-
The University of Manchester Genome Editing Unit (GEU) core facility provides a number of services and is responsible for the generation of custom transgenic mice, genetically modified cell lines
-
clinical, molecular and computational science into a highly convergent programme, with advanced computational biology playing a critical role in our biomarker agenda. An exciting opportunity has arisen for a
-
National Biomarker Centre is a leading and highly specialised translational research centre within The University of Manchester (www.manchester.ac.uk ), core funded by Cancer Research UK
-
Application deadline: All year round Research theme: Applied Mathematics, Imaging How to apply: https://uom.link/pgr-apply-fap This is a fully funded project for home students, funded by NTR-Net. The funding will cover tuition fees and provide a tax free (depending on circumstances) stipend...
-
often have poor solubility in organic solvents. In biology, nucleosides are synthesized efficiently and in a regio- and stereoselective manner by enzymes – thus, biocatalysis offers an attractive
-
, Biological Sciences or a related science, who also possess a desire to do cutting edge research at the Chemistry-Biology interface are encouraged to apply. Professor Jason Micklefield will supervise
-
project involving world leading collaborators in University College London (UCL) and The University of Edinburgh. The University of Manchester is looking to recruit an Engineering Biology Scientist
-
. The postholder will be based at University of Manchester within the group of Michael Brockhurst, but will collaborate closely with the groups of the consortium: Patrick Cai (Manchester Institute of Biotechnology